Flavin-containing monooxygenases: mutations, disease and drug response.
about
Trimethylaminuria: causes and diagnosis of a socially distressing conditionDevelopmental pharmacokinetics in pediatric populationsJoint Functions of Protein Residues and NADP(H) in Oxygen Activation by Flavin-containing MonooxygenaseStructure and mechanism of ORF36, an amino sugar oxidizing enzyme in everninomicin biosynthesis .Qualitative de novo analysis of full length cDNA and quantitative analysis of gene expression for common marmoset (Callithrix jacchus) transcriptomes using parallel long-read technology and short-read sequencingCatalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs)Childhood brain tumors, residential insecticide exposure, and pesticide metabolism genesComparative genome-wide association studies in mice and humans for trimethylamine N-oxide, a proatherogenic metabolite of choline and L-carnitine.Isoform distinct time-, dose-, and castration-dependent alterations in flavin-containing monooxygenase expression in mouse liver after 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment.Effect of various diets on the expression of phase-I drug-metabolizing enzymes in livers of miceFlavin-containing monooxygenase S-oxygenation of a series of thioureas and thiones.Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis.Ecto- and endoparasite induce similar chemical and brain neurogenomic responses in the honey bee (Apis mellifera).Quail FMO3 gene cloning, tissue expression profiling, polymorphism detection and association analysis with fishy taint in eggs.Constraints on the evolution of a doublesex target gene arising from doublesex's pleiotropic deploymentAnalysis of loss-of-function variants and 20 risk factor phenotypes in 8,554 individuals identifies loci influencing chronic diseaseClinical utility gene card for: trimethylaminuria.The phenotype of a knockout mouse identifies flavin-containing monooxygenase 5 (FMO5) as a regulator of metabolic ageing.Clinical utility gene card for: Trimethylaminuria - update 2014Predicting the Metabolic Sites by Flavin-Containing Monooxygenase on Drug Molecules Using SVM Classification on Computed Quantum Mechanics and Circular Fingerprints Molecular Descriptors.Metabolism and pharmacokinetics of the anti-tuberculosis drug ethionamide in a flavin-containing monooxygenase null mouse.Transcriptomic analysis of stage 1 versus advanced adult granulosa cell tumors.Metabolism of the anti-tuberculosis drug ethionamide by mouse and human FMO1, FMO2 and FMO3 and mouse and human lung microsomesThe potentially deleterious functional variant flavin-containing monooxygenase 2*1 is at high frequency throughout sub-Saharan Africa.Characterization of sulfoxygenation and structural implications of human flavin-containing monooxygenase isoform 2 (FMO2.1) variants S195L and N413K.Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.Overview of extracellular microvesicles in drug metabolism.Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population.The potential of knockout mouse lines in defining the role of flavin-containing monooxygenases in drug metabolism.Production of human phase 1 and 2 metabolites by whole-cell biotransformation with recombinant microbes.Pharmacogenetics of olanzapine metabolism.The effects of acute renal failure on drug metabolism.Analysis of gene expression for microminipig liver transcriptomes using parallel long-read technology and short-read sequencing.Inter-individual variation in flavin-containing monooxygenase 3 in livers from Japanese: correlation with hepatic transcription factors.Genetic and Non-genetic Factors Associated with Protein Abundance of Flavin-containing Monooxygenase 3 in Human Liver.Methanobactins: from genome to function.Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG.Drug metabolism by flavin-containing monooxygenases of human and mouse.Human flavin-containing monooxygenase 2.1 catalyzes oxygenation of the antitubercular drugs thiacetazone and ethionamide.Species Differences in the Oxidative Desulfurization of a Thiouracil-Based Irreversible Myeloperoxidase Inactivator by Flavin-Containing Monooxygenase Enzymes.
P2860
Q24604974-DDCD69E8-42F4-4237-A4AD-7AEB4CB72933Q27002933-06744447-47B0-4716-8332-39E121BE9D15Q27664240-69291849-7C0D-4BD8-A19C-AC3C8F8B41E8Q27664658-B9263958-C6EE-47BB-AD27-637515E68909Q28540182-8BC3935B-48DF-4DC7-881E-81B017D9CA75Q30230989-D9F90A66-6F3A-4CCA-8207-5F2C2A5E8627Q33522508-D89DCC84-9BA5-4742-86E6-9ED16B3CF1B2Q33669522-B428530D-3EE7-4CD1-BA7D-68201D2DED2AQ33712363-6C3D6577-1AEB-4BA7-BB00-8E5A2B0E1074Q33894107-9EAF40FD-D7AE-4FE9-8762-E32A4FF4E14EQ33946752-63ED7FE4-41B4-46A4-9E44-60C791FD8D1DQ34757435-9443DE36-6DCF-4496-825B-10BA2B815826Q34833528-C3AFD11F-8395-4499-B462-01B64CE96C7EQ35055301-03A5DED9-09D8-40F6-BFBE-4907C38B58CEQ35134593-6D27FEE1-9276-4E9A-B24C-4E4E317DF0A5Q35751272-5E886E79-AB55-4D3D-9BD5-F33450B08B08Q35768377-B07AFE8D-1241-4EE3-83ED-521B87EB24DBQ35871695-9B8D8617-8AD4-42D4-A7C2-B3E7659A9161Q35959740-2F93DB86-B2EB-4159-AB65-6C48FF82A3E4Q36245456-C870230A-C503-4F68-8816-3276C9F0A912Q36753612-AC694ACB-AAD8-485C-B935-453ADCFECFB2Q37046579-423BD437-55FB-44F3-9854-D3627B77CC8FQ37060764-9975C020-C346-45D2-AA70-5256F9DED062Q37152243-24582A24-7645-416E-8FCD-0446B501C79EQ37266300-47B5EB71-CF72-4C45-B876-5E3A5E44283FQ37357727-C83F4298-4680-4C5B-9643-AE274D347429Q37700753-2F07E66B-33D0-435F-9FC6-75EF9E892986Q37731862-20B6C737-0EE3-47DC-9372-D3F7019B1C26Q37772507-4B0F023B-3C03-4156-AFC3-2ED9F4F39E20Q37810229-E32D15AF-35DC-44B9-BDBC-5F6092EF719AQ38127716-237C99EB-953A-4A18-AC21-47B2EA46A414Q38145416-8FBD1478-DC4C-49E7-9B67-2F11B51ED668Q38446989-DC593A06-8782-4838-A266-99CB36722F7AQ38510442-AC73A259-77FE-4AD2-BEF5-73D38C6A5399Q38619177-0A98E915-16B2-42DE-A0A8-F3CAC31EA896Q38788669-D3FB3AB4-8701-408C-8CBE-8443EB2C1160Q38798449-0E90BFF5-10F6-442F-8E6B-E1F328099BACQ38966423-32F70929-D7EB-4968-A4A4-8AA42526234BQ41763477-AB14966A-B253-4862-9BF7-C79457536C14Q44169005-803FB16E-B93F-4A6F-A7ED-140CF0ECD69D
P2860
Flavin-containing monooxygenases: mutations, disease and drug response.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Flavin-containing monooxygenases: mutations, disease and drug response.
@en
Flavin-containing monooxygenases: mutations, disease and drug response.
@nl
type
label
Flavin-containing monooxygenases: mutations, disease and drug response.
@en
Flavin-containing monooxygenases: mutations, disease and drug response.
@nl
prefLabel
Flavin-containing monooxygenases: mutations, disease and drug response.
@en
Flavin-containing monooxygenases: mutations, disease and drug response.
@nl
P1476
Flavin-containing monooxygenases: mutations, disease and drug response.
@en
P2093
Elizabeth A Shephard
Ian R Phillips
P304
P356
10.1016/J.TIPS.2008.03.004
P577
2008-04-16T00:00:00Z